Furthermore, it modulates the NF-kB pathway by suppressing the inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ), which is overexpressed in CLL [90]. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.